Useful resources |
Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis (Cochrane Review) ABSTRACT Background: Allergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction to colonisation of the lungs with the fungus Aspergillus fumigatus and affects around 10% of people with cystic fibrosis. ABPA is associated with an accelerated decline in lung fu . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |